Skip to main content
    D

    Dr. Reddy’s Laboratories Ltd ADR (RDY)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $14.70
    -0.04 (-0.27%)

    Market Cap: $12.29B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Dr. Reddy’s Laboratories Ltd ADR (RDY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Dr. Reddy’s Laboratories Ltd ADR are Neurocrine Biosciences (NBIX), Elanco Animal Health (ELAN) and Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX). Dr. Reddy’s Laboratories Ltd ADR trades at 39.6x earnings, against a median of 18.4x for the 9 of these companies with a P/E. By market cap, Dr. Reddy’s Laboratories Ltd ADR ranks 9th of the 13 companies on this page; Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest at $68.47B.

    Peer Comparison

    RDY's ROIC of 5.7% is above the peer median of 5.6%, and its revenue growth of -1.5% is below the median of 5.4%. It yields 0.44%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Dr. Reddy’s Laboratories Ltd ADR (RDY)$12.29B39.6x3.5x8.5%5.7%-1.5%0.44%
    Neurocrine Biosciences Inc (NBIX)$16.94B18.4x4.5x19.0%N/A41.2%0.00%
    Elanco Animal Health (ELAN)$13.39B23.2x2.6x-2.9%1.6%11.3%0.00%
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)$7.45B21.4x2.2x4.2%11.6%10.0%0.00%
    Kiniksa Pharmaceuticals Ltd (KNSA)$7.57B72.5x7.8x11.6%N/A58.1%0.00%
    United Therapeutics Corporation (UTHR)$25.18B22.2x7.9x38.6%N/A4.1%0.00%
    Lantheus Holdings Inc (LNTH)$6.64B17.9x4.5x17.3%14.8%1.5%0.00%
    Viatris Inc (VTRS)$23.87B8.1x1.6x-4.1%-0.2%-0.3%2.31%
    Teva Pharma Industries Ltd ADR (TEVA)$51.92B14.4x2.9x2.9%4.3%-1.9%0.00%
    Zoetis Inc (ZTS)$34.06B12.7x3.7x26.4%21.7%-1.3%2.51%
    Hims Hers Health Inc (HIMS)$4.62BN/A1.5x-6.7%-11.1%48.6%0.00%
    Haleon plc (HLN)$40.25BN/A1.6x14.5%13.9%2.2%2.12%
    Takeda Pharmaceutical Co Ltd ADR (TAK)$68.47BN/A2.3x0.9%5.6%6.7%2.92%
    Peer median$20.41B18.4x2.7x7.9%5.6%5.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Dr. Reddy’s Laboratories Ltd ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Neurocrine Biosciences Inc (NBIX)
    Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological...
    NBIX competitors
    Elanco Animal Health (ELAN)
    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals.
    ELAN competitors
    Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)
    Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms...
    AMRX competitors
    Kiniksa Pharmaceuticals Ltd (KNSA)
    Kiniksa Pharmaceuticals Ltd. (KNSA) is an innovative biopharmaceutical company focused on developing breakthrough therapies to address pressing unmet medical...
    KNSA competitors
    United Therapeutics Corporation (UTHR)
    United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs...
    UTHR competitors
    Lantheus Holdings Inc (LNTH)
    Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment...
    LNTH competitors
    Viatris Inc (VTRS)
    Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
    VTRS competitors
    Teva Pharma Industries Ltd ADR (TEVA)
    Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic drugs, specialty drugs...
    TEVA competitors
    Zoetis Inc (ZTS)
    Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.
    ZTS competitors
    Hims Hers Health Inc (HIMS)
    Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals.
    HIMS competitors
    Haleon plc (HLN)
    Haleon plc (HLN) is a leading global consumer health company, emerging as a spin-off from GlaxoSmithKline...
    Takeda Pharmaceutical Co Ltd ADR (TAK)
    Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals...
    TAK competitors

    Frequently Asked Questions About RDY

    Who are Dr. Reddy’s Laboratories Ltd ADR's main competitors?

    The companies most similar to Dr. Reddy’s Laboratories Ltd ADR include Neurocrine Biosciences (NBIX), Elanco Animal Health (ELAN), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Kiniksa Pharmaceuticals (KNSA) and United Therapeutics (UTHR), listed from the closest match.

    Who is Dr. Reddy’s Laboratories Ltd ADR's biggest competitor?

    Takeda Pharmaceutical Co Ltd ADR (TAK) is the largest of the similar companies at $68.47B; Neurocrine Biosciences (NBIX) is the closest match by business profile, size, sector and industry.

    How does RDY stock compare with its competitors?

    RDY's P/E is 39.6x against a peer median of 18.4x; its P/S is 3.5x against a peer median of 2.7x; its net margin is 8.5% against a peer median of 7.9%.

    Which of Dr. Reddy’s Laboratories Ltd ADR's competitors pays a higher dividend?

    Dr. Reddy’s Laboratories Ltd ADR has a forward dividend yield of 0.44%. Takeda Pharmaceutical Co Ltd ADR (TAK), Zoetis (ZTS), Viatris (VTRS) and Haleon (HLN) have higher forward dividend yields; Takeda Pharmaceutical Co Ltd ADR (TAK) has the highest at 2.92%.

    Is Dr. Reddy’s Laboratories Ltd ADR bigger than its competitors?

    No. Dr. Reddy’s Laboratories Ltd ADR is 9th by market cap among the 13 companies on this page; the largest is Takeda Pharmaceutical Co Ltd ADR (TAK) at $68.47B.